D-0182-2027 Class II Ongoing

Recalled by Advagen Pharma Limited — East Windsor, NJ

FDA drug recall D-0182-2027 was initiated by Advagen Pharma Limited on Oct 27, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing. Affected quantity: 3684 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 11, 2026
Initiation Date
Oct 27, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3684 bottles

Product description

Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00.

Reason for recall

Presence of Foreign Tablets/Capsules

Distribution pattern

U.S. Nationwide

Code information

Batch#: 2611C065A1: Expiry: 05/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0182-2027
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Advagen Pharma Limited? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0182-2027. Report a data issue: hello@regdatalab.com.